← back to search

M.E. Rodrigo

Virginia Commonwealth University · US
Area of research
Biomedical Engineering · Surgery
Research interest
Research focused on Heart transplantation and Donor specific antibodies, with related work in Antibody, Transplantation, Inter-rater reliability. Notable publications include 'Circulating microRNAs in cellular and antibody-mediated heart transplant rejection', 'Pathologist interrater reliability and clinical implications of elevated donor-derived cell-free DNA beyond heart transplant rejection, on behalf of the GRAfT investigators', and 'Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators'.
h-index
citations
98
works
9
NIH funding
primary concept
email

Recent publications

Pathologist interrater reliability and clinical implications of elevated donor-derived cell-free DNA beyond heart transplant rejection, on behalf of the GRAfT investigators
The Journal of Heart and Lung Transplantation 2024cited by 18position: middledoi
Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators
Circulation Heart Failure 2024cited by 16position: middledoi
Redefining Cardiac Antibody-Mediated Rejection With Donor-Specific Antibodies and Graft Dysfunction
Circulation Heart Failure 2024cited by 14position: middledoi
Proteomics in Acute Heart Transplant Rejection, on Behalf of the GRAfT Investigators
Transplantation 2024cited by 6position: middledoi
Cell-Free DNA Identifies High-Risk Donor Specific Antibodies in Heart Transplant Recipients
The Journal of Heart and Lung Transplantation 2024cited by 1position: middledoi
Circulating microRNAs in cellular and antibody-mediated heart transplant rejection
The Journal of Heart and Lung Transplantation 2022cited by 42position: middledoi
Circulating microRNA Biomarkers in Cellular and Antibody-Mediated Heart Transplant Rejection
The Journal of Heart and Lung Transplantation 2022cited by 1position: middledoi
Cell-Free DNA to Distinguish High Risk Donor Specific Antibodies in Heart Transplantation
The Journal of Heart and Lung Transplantation 2022cited by 0position: middledoi
Response by Shah et al to Letter Regarding Article, “Cell-Free DNA to Detect Heart Allograft Acute Rejection”
Circulation 2021cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Gerald J. Berry · Stanford University9 papers (2021–2024)Hannah A. Valantine · Palo Alto University9 papers (2021–2024)Charles C. Marboe · NewYork–Presbyterian Hospital9 papers (2021–2024)Sean Agbor-Enoh · National Institutes of Health9 papers (2021–2024)Moon Kyoo Jang · National Institutes of Health9 papers (2021–2024)Samer S. Najjar · MedStar Health9 papers (2021–2024)Keyur B. Shah · University College London8 papers (2021–2024)Palak Shah · Inova Fairfax Hospital8 papers (2021–2024)Hyesik Kong · Georgetown University7 papers (2021–2024)Steven Hsu · Johns Hopkins University7 papers (2021–2024)Inna Tchoukina · Virginia Commonwealth University6 papers (2022–2024)Jason F. Goldberg · University of Virginia4 papers (2024–2024)Erika Feller · Drexel University4 papers (2021–2024)T. Andargie · National Heart Lung and Blood Institute3 papers (2024–2024)Pramita Bagchi · George Washington University3 papers (2022–2024)Erick McNair · University of Saskatchewan3 papers (2024–2024)Christopher R. deFilippi · Inova Fairfax Hospital3 papers (2022–2024) · 2 papers (2024–2024)Kiran K. Khush · Palo Alto University2 papers (2022–2022)Shashank S. Sinha · Inova Fairfax Hospital2 papers (2024–2024)